Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cappellini

Showing results (261-270 of 1,084) with videos related to

Pageof 109
Sort By:
Cancer|January 14, 2017
Reply to Management of hepatocellular carcinoma in thalassemia and importance of the human factorHassan M Moukhadder, Racha Halawi, Maria Domenica Cappellini, et al.
Letters in Applied Microbiology|October 13, 2016
Reducing time to identification of aerobic bacteria and fastidious micro-organisms in positive blood culturesJ Intra, M R Sala, R Falbo, et al.
Minerva Medica|February 21, 1974
[Autoantibodies and Australia antigen in acute and chronic liver]S R Fargion, E Del Ninno, M D Cappellini, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1974
Evaluation of cellular immunity in chronic liver diseases during immunosuppressive treatmentF Salerno, G Tornaghi, M D Cappellini, et al.
Micromachines|March 28, 2024
Tool Run-Out in Micro-Milling: Development of an Analytical Model Based on Cutting Force Signal AnalysisAndrea Abeni, Cristian Cappellini, Greta Seneci, et al.
Human Genetics|February 14, 2007
Gene symbol: FECH. Disease: Porphyria, erythropoietic. Accession #Hg0501E Di Pierro, V Brancaleoni, V Moriondo, et al.
Human Genetics|January 19, 2007
Gene symbol: HMBS. Disease: porphyria, acute intermittentE Di Pierro, V Besana, V Brancaleoni, et al.
Human Genetics|February 24, 2006
Gene symbol: HMBS. Disease: porphyria, acute intermittentE Di Pierro, V Besana, V Moriondo, et al.
Brain Research. Molecular Brain Research|January 8, 1999
Characterization of a cloned xenopus laevis serotonin 5-HT1A receptor expressed in the NIH-3T3 cell lineC Cappellini, P Malatesta, B Costa, et al.
Hemoglobin|December 10, 2008
Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]John B Porter, Ali T Taher, Maria D Cappellini, et al.
Pageof 109

Showing results (261-270 of 1,084) with videos related to

Sort By:
Pageof 109
Cancer|January 14, 2017
Reply to Management of hepatocellular carcinoma in thalassemia and importance of the human factorHassan M Moukhadder, Racha Halawi, Maria Domenica Cappellini, et al.
Letters in Applied Microbiology|October 13, 2016
Reducing time to identification of aerobic bacteria and fastidious micro-organisms in positive blood culturesJ Intra, M R Sala, R Falbo, et al.
Minerva Medica|February 21, 1974
[Autoantibodies and Australia antigen in acute and chronic liver]S R Fargion, E Del Ninno, M D Cappellini, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1974
Evaluation of cellular immunity in chronic liver diseases during immunosuppressive treatmentF Salerno, G Tornaghi, M D Cappellini, et al.
Micromachines|March 28, 2024
Tool Run-Out in Micro-Milling: Development of an Analytical Model Based on Cutting Force Signal AnalysisAndrea Abeni, Cristian Cappellini, Greta Seneci, et al.
Human Genetics|February 14, 2007
Gene symbol: FECH. Disease: Porphyria, erythropoietic. Accession #Hg0501E Di Pierro, V Brancaleoni, V Moriondo, et al.
Human Genetics|January 19, 2007
Gene symbol: HMBS. Disease: porphyria, acute intermittentE Di Pierro, V Besana, V Brancaleoni, et al.
Human Genetics|February 24, 2006
Gene symbol: HMBS. Disease: porphyria, acute intermittentE Di Pierro, V Besana, V Moriondo, et al.
Brain Research. Molecular Brain Research|January 8, 1999
Characterization of a cloned xenopus laevis serotonin 5-HT1A receptor expressed in the NIH-3T3 cell lineC Cappellini, P Malatesta, B Costa, et al.
Hemoglobin|December 10, 2008
Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]John B Porter, Ali T Taher, Maria D Cappellini, et al.
Pageof 109